On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) has released its CY 2023 Medicare Physician Fee Schedule (PFS) proposed rule which includes proposals related to Medicare physician payment and the Quality Payment Program (QPP). Within the fee schedule, CMS proposed Medicare payment cuts to the Anesthesia Conversion Factor and the bundling of certain procedure codes that will only compound the financial strain that anesthesia groups are already facing. The proposed rule has a 60-day comment period and is expected to be published in the federal register on July 11, 2022. Final regulations will be issued on or around November 1 and unless otherwise noted, policies will be effective January 1, 2023.
ASA opposes these additional Medicare payment cuts included in the CY 2023 PFS proposed rule. The proposed rule underscores how the Medicare payment system is broken, especially during a time when anesthesia groups are faced with inflation pressures and the COVID-19 pandemic. ASA has urged and will continue to advocate to legislative stakeholders and regulatory agencies to minimize and reverse these cuts that negatively impact anesthesiologists.
Fee Schedule Provisions:
The 2023 proposed anesthesia conversion factor (CF) is 20.7191, representing a decrease of 3.91% from the 2022 anesthesia CF of $21.5623. The 2023 proposed RBRVS CF is 33.0775. This represents a decrease of 4.42% from the 2022 CF of 34.6062. The CFs are proposed to decrease because of two factors:
2022 CF | Proposed 2023 CF | Percent Change | |
Anesthesia | $21.5623 | $20.7191 | -3.91% |
RBRVS | $34.6062 | $33.0775 | -4.42% |
Specialty Impact on Anesthesia and Pain Medicine
Actual payment rates are impacted by a range of proposed policy changes related to physician work, practice expense, and malpractice RVUs. CMS summarized these changes in Table 138 in the proposed rule. Impact by practice will vary based on service mix. Specialty impacts ranged from -4% for Interventional Radiology, to +5% for Infectious Disease. The table indicates that the impact of policies in the proposed rule will have a -1% impact on anesthesiology and on interventional pain management.
Specialty | Allowed Charges (mil) | Impact of work RVU Changes | Impact of PE RVU Changes |
Impact of Malpractice
|
Combined Impact
|
Anesthesiology | $1,741
|
-1% | 0% | 0% | -1% |
Nurse Anesthetist/ Anesthesiologist Assistant | $1,116 | -1% | 0% | 0% | -1% |
Interventional Pain Management | $924 | -1% | -1% | 0% | -1% |
*Note: Combined Impact may not equal the sum of work, PE and malpractice due to rounding.
Source: Table 138, CY 2023 Proposed PFS, display copy
Pain Medicine Code Updates
Pain medicine physicians are likely to see a decrease in certain payments based upon an emerging trend to bundle payments for procedures with imaging. CPT codes 64415, 64416, 64417, 64445, 64446, 64447 and 64448 describe only injection of an anesthetic agent in the area of the peripheral nerve and/or catheter placement for postoperative pain management. In recent years these codes are frequently reported (over 75% of the time) with imaging (76942 ultrasound imaging). Due to the frequent reporting of imaging, these codes were identified by the CPT Editorial Panel and the RVS Update Committee (RUC) to be revised and imaging was bundled into the procedure codes. These codes will be effective January 1, 2023, and CMS has proposed new values for these services.
ASA is reviewing these proposals and will advocate on behalf of members to CMS that pain medicine services are appropriately and fairly-valued.
The table below reflects CMS’s proposed reduced work RVUs for the new bundled codes as compared to when the procedure and imaging are billed separately.
Code | Descriptor * | 2022 wRVU (Procedure code + 76942) | 2023 Proposed wRVU (Bundled Code) |
64415 | Injection(s), anesthetic agent(s) and/or steroid; brachial plexus, including imaging guidance, when performed | 2.02 | 1.35 |
64416 | Injection(s), anesthetic agent(s) and/or steroid; brachial plexus, continuous infusion by catheter (including catheter placement) including imaging guidance, when performed | 2.15 | 1.65 |
64417 | Injection(s), anesthetic agent(s) and/or steroid; axillary nerve, including imaging guidance, when performed | 1.94 | 1.31 |
64445 | Injection(s), anesthetic agent(s) and/or steroid; sciatic nerve, including imaging guidance, when performed | 1.67 | 1.28 |
64446 | 64446 Injection(s), anesthetic agent(s) and/or steroid; sciatic nerve, continuous infusion by catheter (including catheter placement) including imaging guidance, when performed | 2.03 | 1.64 |
64447 |
Injection(s), anesthetic agent(s) and/or steroid; femoral nerve, including imaging guidance, when performed | 1.77
|
1.34
|
64448
|
Injection(s), anesthetic agent(s) and/or steroid; femoral nerve, continuous infusion by catheter (including catheter placement) including imaging guidance, when performed |
2.08
|
1.68
|
*Updated code description for 2023 to include imaging
Code | Descriptor * | 2023 Proposed wRVU |
GYYY1 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care (e.g. physical therapy and occupational therapy, and communitybased care), as appropriate. Required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (When using GYYY1, 30 minutes must be met or exceeded.) | 1.45 |
GYYY2 | Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month (List separately in addition to code for GYYY1). (When using GYYY2, 15 minutes must be met or exceeded.) | 0.50 |
Anesthesiologists will have the opportunity to report the Anesthesiology MIPS Value Pathway in 2023. MIPS Value Pathways, CMS believes, will alleviate some of the reporting burdens that anesthesiologists and other physicians encounter in the MIPS program.
For more information on the Quality Payment Program, please contact the ASA Department of Quality and Regulatory Affairs (QRA) at [email protected].
ASA leaders and staff will review the rule and submit comments by the deadline. Unless otherwise notes, finalized provisions will become effective January 1, 2023.
For more Information:
Medicare PFS Proposed Rule fact sheet